相似文献
1
Hepatocellular carcinoma markers in the omics era: the glycomic analysis.
Hepatobiliary Surg Nutr. 2014 Dec;3(6):407-9. doi: 10.3978/j.issn.2304-3881.2014.07.04.
2
Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis.
Hepatology. 2013 Jun;57(6):2314-25. doi: 10.1002/hep.26262. Epub 2013 Apr 26.
3
Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.
World J Gastroenterol. 2015 May 28;21(20):6167-79. doi: 10.3748/wjg.v21.i20.6167.
4
Large-scale glycomics for discovering cancer-associated N-glycans by integrating glycoblotting and mass spectrometry.
Methods Enzymol. 2010;478:109-25. doi: 10.1016/S0076-6879(10)78004-6.
5
Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma.
Front Oncol. 2018 Jan 15;7:328. doi: 10.3389/fonc.2017.00328. eCollection 2017.
6
Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
PLoS One. 2018 Dec 28;13(12):e0209515. doi: 10.1371/journal.pone.0209515. eCollection 2018.
7
N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
Hepatology. 2007 Nov;46(5):1426-35. doi: 10.1002/hep.21855.
8
Discovery of Pancreatic Ductal Adenocarcinoma-Related Aberrant Glycosylations: A Multilateral Approach of Lectin Microarray-Based Tissue Glycomic Profiling With Public Transcriptomic Datasets.
Front Oncol. 2020 Mar 13;10:338. doi: 10.3389/fonc.2020.00338. eCollection 2020.
9
Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d/d)phenyl-3-methyl-5-pyrazolone followed by mass spectrometric analysis.
J Proteomics. 2017 Jan 6;150:18-30. doi: 10.1016/j.jprot.2016.08.012. Epub 2016 Aug 29.
10
A comprehensive glycome profiling of Huntington's disease transgenic mice.
Biochim Biophys Acta. 2015 Sep;1850(9):1704-18. doi: 10.1016/j.bbagen.2015.04.006. Epub 2015 Apr 20.
引用本文的文献
1
Structural changes of proteins in liver cirrhosis and consequential changes in their function.
World J Gastroenterol. 2022 Aug 7;28(29):3780-3792. doi: 10.3748/wjg.v28.i29.3780.
2
The Interplay of Inflammatory Processes and Cognition in Alcohol Use Disorders-A Systematic Review.
Front Psychiatry. 2019 Sep 12;10:632. doi: 10.3389/fpsyt.2019.00632. eCollection 2019.
3
Systems Challenges of Hepatic Carcinomas: A Review.
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):233-244. doi: 10.1016/j.jceh.2018.05.002. Epub 2018 May 17.
4
NRAGE is a potential diagnostic biomarker of hepatocellular carcinoma.
Medicine (Baltimore). 2018 Nov;97(48):e13411. doi: 10.1097/MD.0000000000013411.
5
Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma.
Front Oncol. 2018 Jan 15;7:328. doi: 10.3389/fonc.2017.00328. eCollection 2017.
6
Alteration of liver glycopatterns during cirrhosis and tumor progression induced by HBV.
Glycoconj J. 2016 Apr;33(2):125-36. doi: 10.1007/s10719-015-9645-z. Epub 2016 Jan 30.
7
Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
Br J Cancer. 2015 Mar 31;112(7):1141-56. doi: 10.1038/bjc.2015.38.
本文引用的文献
1
Carbohydrate 19.9 antigen serum levels in liver disease.
Biomed Res Int. 2013;2013:531640. doi: 10.1155/2013/531640. Epub 2013 Oct 27.
2
Systemic therapies in hepatocellular carcinoma: present and future.
Future Oncol. 2013 Oct;9(10):1533-48. doi: 10.2217/fon.13.171.
3
Serum markers of intrahepatic cholangiocarcinoma.
Dis Markers. 2013;34(4):219-28. doi: 10.3233/DMA-130964.
4
Autoimmunity in the elderly: Implications for cancer.
J Cancer Res Ther. 2012 Oct-Dec;8(4):520-7. doi: 10.4103/0973-1482.106527.
5
Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis.
Hepatology. 2013 Jun;57(6):2314-25. doi: 10.1002/hep.26262. Epub 2013 Apr 26.
6
7
The role of immunity in elderly cancer.
Crit Rev Oncol Hematol. 2010 Apr;74(1):40-60. doi: 10.1016/j.critrevonc.2009.06.002. Epub 2009 Jul 4.
8
Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines.
Dis Markers. 2008;25(4-5):243-58. doi: 10.1155/2008/515318.
9
Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
Int J Gynecol Cancer. 2008 May-Jun;18(3):470-5. doi: 10.1111/j.1525-1438.2007.01028.x. Epub 2007 Jul 26.
10
Sweet clearance: involvement of cell surface glycans in the recognition of apoptotic cells.
Autoimmunity. 2007 Jun;40(4):345-8. doi: 10.1080/08916930701356804.
Zotero 插件